Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Yamamura

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 1, 2018
[113th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Gut microbiota and diseases: Gut Microbiota and Multiple Sclerosis]Takashi Yamamura
Rinsho Shinkeigaku = Clinical Neurology|January 27, 2012
[Antibody treatment for multiple sclerosis and neuromyeitis optica]Takashi Yamamura
The Lancet. Neurology|November 21, 2022
Time to reconsider the classification of multiple sclerosisTakashi Yamamura
Neurochemistry International|August 5, 2019
Editorial: NeuroimmunologyTakashi Yamamura
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 25, 2009
[Molecular target drug development for curing multiple sclerosis]Takashi Yamamura
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 11, 2021
[Multiple Sclerosis and Gut Microbiome: Current Research and Perspective]Takashi Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2003
[Involvement of NK and NKT cells in the pathogenesis of multiple sclerosis]Takashi Yamamura
Brain and Nerve = Shinkei Kenkyu No Shinpo|June 10, 2016
[Multiple Sclerosis and Commensal Gut Flora]Takashi Yamamura
Rinsho Shinkeigaku = Clinical Neurology|June 6, 2003
[Hypothetical view on the environmental factors, Th1/Th2 balance, and disease phenotype of MS/EAE]Takashi Yamamura
Current Rheumatology Reports|May 16, 2007
Interleukin 17-producing T-helper cells and autoimmune diseases: time for a paradigm shift?Takashi Yamamura
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 1, 2018
[113th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Gut microbiota and diseases: Gut Microbiota and Multiple Sclerosis]Takashi Yamamura
Rinsho Shinkeigaku = Clinical Neurology|January 27, 2012
[Antibody treatment for multiple sclerosis and neuromyeitis optica]Takashi Yamamura
The Lancet. Neurology|November 21, 2022
Time to reconsider the classification of multiple sclerosisTakashi Yamamura
Neurochemistry International|August 5, 2019
Editorial: NeuroimmunologyTakashi Yamamura
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 25, 2009
[Molecular target drug development for curing multiple sclerosis]Takashi Yamamura
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 11, 2021
[Multiple Sclerosis and Gut Microbiome: Current Research and Perspective]Takashi Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2003
[Involvement of NK and NKT cells in the pathogenesis of multiple sclerosis]Takashi Yamamura
Brain and Nerve = Shinkei Kenkyu No Shinpo|June 10, 2016
[Multiple Sclerosis and Commensal Gut Flora]Takashi Yamamura
Rinsho Shinkeigaku = Clinical Neurology|June 6, 2003
[Hypothetical view on the environmental factors, Th1/Th2 balance, and disease phenotype of MS/EAE]Takashi Yamamura
Current Rheumatology Reports|May 16, 2007
Interleukin 17-producing T-helper cells and autoimmune diseases: time for a paradigm shift?Takashi Yamamura
Pageof 24